Cartesian Therapeutics Inc (NAS:RNAC)
$ 17.91 -0.74 (-3.97%) Market Cap: 455.18 Mil Enterprise Value: 250.63 Mil PE Ratio: 0 PB Ratio: 577.74 GF Score: 56/100

Q2 2021 Selecta Biosciences Inc Earnings Call Transcript

Aug 12, 2021 / 12:30PM GMT
Release Date Price: $131.1 (+14.40%)
Operator

Good morning, everyone, and welcome to the Selecta Biosciences Second Quarter 2021 Financial Results and Corporate Update Conference Call. (Operator Instructions) This call is being webcast live on the Investors and Media section of Selecta's website at www.selectabio.com and is being recorded.

For opening remarks, I would like to introduce Kristen Baldwin, Chief People Officer of Selecta. Please go ahead.

Kristen Baldwin
Selecta Biosciences, Inc. - Chief People Officer

Thank you and good morning. Welcome to our second quarter 2021 financial results and corporate update conference call. The press release reporting our financial results is available in the Investor and Media section of Selecta's website, www.selectabio.com, and the quarterly report on Form 10-Q ended June 30, 2021, which was filed today with the SEC.

Joining me today are Carsten Brunn, President and Chief Executive Officer; Peter Traber, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot